Krazati Adagrasib — Carefirst Caremark
5 indications indexed for this drug.
- Advanced Or Metastatic Colorectal Cancer Including AppendiceView coverage criteria
- Progressive Ampullary AdenocarcinomaView coverage criteria
- Recurrent Advanced Or Metastatic Kras G12c Mutation PositiveView coverage criteria
- Recurrent Locally Advanced Or Metastatic Pancreatic AdenocarView coverage criteria
- Unresectable Resected Gross Residual R2 Or Metastatic BiliarView coverage criteria